Overview

Efficacy of Repaglinide in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2003-03-06
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to compare the efficacy of repaglinide to glyburide and placebo on hepatic glucose metabolism in subjects with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glyburide
Repaglinide